Skip to content

Laetitia Bénard

Associée

Paris

Benard Laetitia
Laetitia Bénard

Associée

Paris

Laëtitia Bénard est associée au sein du département Propriété Intellectuelle et Contentieux d'Allen & Overy Paris. Elle dirige le département Propriété Intellectuelle à Paris et co-dirige le groupe Sciences de la Vie d'Allen & Overy au niveau mondial.

Sa pratique professionnelle couvre tous les domaines de la propriété intellectuelle, où elle intervient tant en conseil qu’en contentieux, en matière de brevets, marques, de droits d’auteur et de concurrence déloyale notamment. Elle assiste également ses clients dans le secteur pharmaceutique sur les aspects réglementaires et contractuels de leur activité.

Laëtitia est l'auteur de plusieurs chapitres dans l'ouvrage Concurrence, Santé publique, Innovation et Médicaments, de Generic drugs and IP law et de la Question 202 du groupe français de l'AIPPI sur "The impact of public health issues on exclusive patents rights".

Plus récemment, elle a co-écrit notamment les articles "L'arrêt DHL/Chronopost de la CJUE du 12 avril 2011 : une injonction communautaire peut être obtenue dans les limites de l'atteinte aux fonctions de la marque "(Lamy Droit de l'Immatériel, 2011), "Why France is a good forum for preliminary injunctions in patent matters" (Global Business Magazine, avril 2012), "Supplementary Protection Certificates : the CJEU provides Welcome Clarifications" (Who's Who Legal – Life Sciences, 2012) et "Trade Secrets Protection: a Comparative Overview" (Handbook of European IP Management 2012), "Comparative Advertising for Generics in Germany and France after L’Oréal v Bellure" (PTMG Law Lore & Practice, décembre 2012), "Overview of Life Sciences law in France" (à paraître dans le Chambers Life Sciences Guide 2013) et "Comparative Advertising for Generics in Germany and France after L’Oréal v Bellure" (PTMG Law Lore & Practice, décembre 2012).

Laëtitia is a recognised practitioner by « Best Lawyers » since 2013 in Biotechnology and Life Sciences Practice, Intellectual Property Law, Litigation and Regulatory Practice"".

Patent Litigator of the Year: Pharmaceuticals
LMG Life Sciences EMEA Awards 2023

“Laëtitia is the absolute top practitioner in her life science niche. She has unparalleled expertise worldwide in certain active ingredients.” “She defends for some of the world’s most renowned pharmaceutical innovators against generic competitors.”
IAM Patent 1000 2023 - France (IP/Patent)

Gold
IAM Patent 1000 2023 - France (IP/Patent)
 
Patent Litigator of the Year: Pharmaceuticals
LMG Life Sciences EMEA Awards 2023
 
Thought Leader - Global Leader – National Leader
Who's Who Legal 2023 – France in Patents and Life Sciences

Band 1 (Pharma/Life Sciences: Intellectual Property)
Chambers Global/Europe 2023 - France (Pharma / Life Sciences)

""Laëtitia Bénard remains a key name in the market and is recognised for her expertise in domestic and multi-jurisdictional patent litigations. She represents leading global pharmaceutical companies in proceedings at the French and European level.""

""Laëtitia can deal with complex litigation, she knows the French court system Inside out and is a very good strategic litigator.""
Chambers Global/Europe 2023 - France (Pharma / Life Sciences)

Band 1
Chambers Global/Europe 2023 - France (Intellectual Property: Patents)

Laëtitia Bénard demonstrates leading experience in contentious patent mandates, including infringement claims and nullity actions. Her vast experience in the life sciences field means that she is regularly sought after by major pharmaceutical companies.

""She is one of the best lawyers I have dealt with in France. She is very creative and proactive, extremely thorough, sensible in her advice and is successful in tough cases.""

""We appreciate her strategic vision of the cases and her very reassuring approach.""

""She is one of the best lawyers of her generation.""
Chambers Global/Europe 2023 - France (Intellectual Property: Patents)

Leading individual
Legal 500 EMEA 2023 - France (Healthcare & Life Sciences)

Hall of Fame
Legal 500 EMEA 2023 - France (Intellectual Property: Patents)

""Laetitia Bénard is a wonderful advocate. Dedicated to her clients, bright, demanding, determined. Top choice in France in the pharma sector.""
Legal 500 EMEA 2023 - France (Intellectual Property: Patents)

Band 1 (Pharma/Life Sciences: Intellectual Property)
Chambers Global/Europe 2022 - France (Pharma / Life Sciences)

"Laëtitia Bénard remains a key name in the market and is recognised for her expertise in domestic and multi-jurisdictional patent litigations. She represents leading global pharmaceutical companies in proceedings at the French and European level. A client stresses that she is "thorough, sophisticated and an all-around fantastic lawyer."
Chambers Global/Europe 2022 - France (Pharma / Life Sciences)

Band 1
Chambers Global/Europe 2022 - France (Intellectual Property: Patents)

"Laëtitia Bénard is "one of the leaders on the market," according to sources. She demonstrates strong experience in contentious patent mandates and nullity actions. Clients report: 'She is thorough and is a good advocate in court and hearings,' further adding: 'She is active and successful'."
Chambers Global/Europe 2022 - France (Intellectual Property: Patents)

Hall of Fame
Legal 500 EMEA 2022 - France (Healthcare & Life Sciences)

"Laetitia has raised novel factual and legal arguments that had not been made elsewhere, and her arguments have been used by the attorneys in the other countries where related cases were pending."
Legal 500 EMEA 2022 - France (Healthcare & Life Sciences)

Leading Individual
Legal 500 EMEA 2022 - France (Intellectual Property: Patents)

"Laetitia Bénard is a wonderful advocate. Dedicated to her clients, bright, demanding, determined. Top choice in France in the pharma sector."
Legal 500 EMEA 2022 - France (Intellectual Property: Patents)

Silver for Enforcement and Litigation
Silver for Prosecution and Strategy
WTR1000 2022 - France (IP / Trademark)

Recommended Individual
Juve Patent 2022 - France (IP / Patent)

Patent star 2021 
Top 250 Women in IP 2021
Trade mark star 2021
Managing IP 2021 - France (Intellectual Property)

Gold
IAM Patent1000 2021 - France (IP/Patent)

"Laëtitia Bénard remains a key name in the market and is recognised for her expertise in domestic and multi-jurisdictional patent litigations. She represents leading global pharmaceutical companies in proceedings at the French and European level."
Chambers Europe 2021 - France (Pharma/Life Sciences)

"Laëtitia Bénard garners high praise from clients, who applaud her extensive experience and very good strategic knowledge. She is recognised for her expertise in patents and she often acts on patent-related litigations."
Chambers Global/Europe 2021 - France (Intellectual Property: Patents)

Top 250 Women in IP 2021
Managing IP 2021

Silver - Enforcement and Litigation 
WTR 1000 2021 - France (IP/Trademark)

Silver - Prosecution and Strategy 
WTR 1000 2021 - France (IP/Trademark)

Recommended Individual
JUVE Patent 2021 - France (IP/Patent)

Trade mark star 
IP Stars - Rising Stars 2020/2021 - France (Trade mark contentious)

"Hall of Fame"
Legal 500 EMEA 2021 - France (Intellectual Property: Patents)

"Laëtitia Bénard is always available, competent and one of the best lawyers in the field."
Legal 500 EMEA 2021 - France (Healthcare & Life Sciences)

Grand avocat du marché
Legal 500 EMEA 2020 - France (Brevets)

"Laëtitia Bénard et son équipe, sont très expérimentées, en particulier dans les affaires de brevet/ SPC dans le secteur pharmaceutique. Respectée, tournée vers le client, réactive, créative, pragmatique."
Legal 500 EMEA 2020 - France (Brevets)

"Laëtitia Bénard, doyenne des litiges dans le domaine des sciences de la vie au nom des initiateurs, affiche une détermination agressive pour gagner. C’est une vraie battante, créative, formidable au tribunal, aux contributions érudites, c’est un vrai plaisir de travailler avec elle."
Legal 500 EMEA 2020 - France (Santé et Sciences de la vie)

Grand avocat du marché
Legal 500 EMEA 2020 - France (Santé et Sciences de la vie) 

"Laëtitia Bénard travaille sans relâche. Elle connaît très bien le droit pharmaceutique, mais aussi le droit des biotechnologies et de l’informatique."
Legal 500 EMEA 2020 - France (Santé et Sciences de la vie) 

Patent Lawyer of the Year
Women in Business Law Awards 2021 - Europe

Leading individual in patent litigation
Juve Patent 2021 - France

Ranked Silver for Enforcement & Litigation and Prosecution & Strategy
World Trademark Review 1000, 2021
 
"Esteemed litigator and firm board member"
World Trademark Review 1000, 2021
 
Intellectual Property Lawyer of the Year in France
Global Law Experts, 2021
 
Life Sciences Lawyer of the Year in France
Global Law Experts, 2021
 
Domestic and Cross-Border Patent Litigation Lawyer of the Year in France
Global Law Experts, 2021
 
Elite practitioner in IP
World IP Review, Leaders Guide, 2021
 
Intellectual Property Lawyer of the Year in France
Corporate International Global Awards, 2021
 
Life Sciences Lawyer of the Year in France
Corporate International Global Awards, 2021
 
Domestic and Cross-Border Patent Litigation Lawyer of the Year in France
Corporate International Global Awards, 2021
 
Global Leader
IAM Patent, 2021
 
Patent star
IP Star 2020-2021
 
Top 250 Women in IP 2020
IP Star 2020-2021
 
Trade mark star 2020/21
IP Star 2020-2021
 
Lawyer of the Year in Intellectual Property Law 
Best Lawyers Awards - France 2021
 
"Laëtitia Bénard leads the charge and regularly appears in high-profile international patent suits, most recently on behalf of Novartis. The co-head of Allen & Overy’s worldwide life sciences group is noted for her unique ability to advise on pharmaceutical regulatory issues and their interplay with intellectual property." 
IAM Patent 1000 2020 - France
 
Laëtitia Bénard - Ranked Gold in Litigation 
IAM Patent 1000 2020 - France
 
Best Lawyer in France in Biotechnology and Life Sciences - Intellectual Property Law 
Best Lawyers 2020
 
Life Sciences Firm of the Year (France)
LMG Life Sciences Awareds Europe 2020
 
"Very strong in pharma proceedings” 
Juve – France 2020
 
"Leading Individual"
Legal 500 EMEA 2020 – France (INTELLECTUAL PROPERTY: PATENTS)
 
"Laëtitia Bénard, with her team, is very experienced, in particular in patent/SPC matters in the pharmaceutical field. Respected, client-oriented, responsive, creative, pragmatic." 
Legal 500 EMEA 2020 – France (INTELLECTUAL PROPERTY: PATENTS)

"Leading Individual"
Legal 500 EMEA 2020 – France (HEALTHCARE & LIFE SCIENCES)
 
"Laëtitia Bénard, who co-heads the firm's life sciences group worldwide, is second to none in patent litigation." 
Legal 500 EMEA 2020 – France (HEALTHCARE & LIFE SCIENCES)
 
Band 1
Chambers Global/Europe 2020 - France (Pharma/Life Sciences: Intellectually Property)

The "extremely talented" Laëtitia Bénard is renowned as a patent litigator, most notably acting for high-profile pharmaceutical companies. One source says she is "very knowledgeable," before going on to add that she has a "very good grasp of IP enforcement in France." 
Chambers Global/Europe 2020 - France (Pharma/Life Sciences: Intellectually Property)

Leader
IAM Global Leaders Guide 2020 
 
Global leader in Patents 
Who's Who Legal 2020
 
"Litigator Laëtitia Bénard heads both the IP practice in Paris and Allen & Overy’s life sciences group globally, gathering plaudits from the market for her finely tuned high-tech and pharmaceutical advice." 
IAM Patent 1000 2019 - France
 
Laëtitia Bénard - Ranked Gold in Litigation 
IAM Patent 1000 2019 - France
 
Global Leader in Life Sciences - Patent Litigation 2019, Patents 2019 and National Leader France - Life Sciences, France - Patents 
Who's Who Legal 2019

Silver for enforcement and litigation; prosecution and strategy 
WTR 1000- 2018-2019 

Leading Individual 
LEGAL 500 EMEA 2018-2019 – France (Intellectual Property: Patents) 

"Best in Patent" 
Euromoney LMG Europe Women in Business Law Awards 2019
 
"Intellectual Property Lawyer of the Year" 
Benchmark Litigation Europe 2019 
 
"Laëtitia Bénard specialises in pharmaceutical patent litigation and is lauded as "an excellent lawyer for contentious matters." Another source enthuses: "She is famous for being a hard-working, excellent lawyer for patent matters," adding: "She is a determined and effective presence in court."" 
Chambers 2019 - France (Pharma/Life Sciences)

"Laëtitia Bénard is a market leader in IP and primarily acts on patent litigation cases for pharmaceutical companies. She is highly respected by clients and peers who highlight her client dedication and industry knowledge. She assisted Pfizer with a patent litigation case concerning the validity of a second medical use patent." 
Chambers 2019 - France (Intellectual Property)
 
"Leading Life sciences practitioner in France." 
Euromoney Expert Guides: Best of the Best Global Awards 2019 

"Litigation Star for IP Litigation in France " 
Benchmark Europe 2019 

“IP Star” and “Top 250 Woman in IP”
Managing IP – Patents and Trademark 2018

“Laëtitia Bénard is described by clients as "very impressive" and "very knowledgeable about the pharmaceutical industry as a whole." She is further praised for her cross-border capabilities and her "pragmatic and result-oriented" nature.” 
Chambers Europe 2018 - France (Pharma/Life Sciences)
 
“Laëtitia Bénard is head of the firm's Paris IP practice. Clients say: "She is able to grasp complex issues and thinks about the big picture.” 
Chambers Europe 2018 - France (Intellectual Property)
 
"Peers shower Bénard with praise: ‘She’s an extremely hard worker with a tremendous reputation. Her importance in the IP scene is unquestionable.’.” 
IAM Patent 1000 2018 - France
 
“Pharmaceuticals powerhouse Bénard’s extremely impressive in court and has a strong understanding of procedural issues.” 
WTR 1000 2018

"Laëtitia is managing the team well," says a market commentator. According to one client, Bénard is "highly skilled in litigation". Another client adds: "Laëtitia is the go-to lawyer for life sciences companies and her skills are second to none."
Managing IP Europe 2018

Laëtitia Bénard heads the IP and litigation department: "She is incredibly capable, knows her cases extremely well, anticipates questions before they arise and has a complete grasp of all aspects of IP litigation issues in France". 
IAM Patent 1000 2017 - France
 
"Practice head Laëtitia Bénard is ‘very impressive and the must-use lawyer in the life sciences area’." 
Legal 500 EMEA 2017 – France (Intellectual Property: Patents)
 
"Laëtitia Bénard excels in all aspects of IP with a particular focus on the life sciences sector." 
Chambers Europe 2017 - France (Intellectual Property)

"Laëtitia Bénard is described as a 'very present and important' practitioner in the market. She has particular expertise in the life sciences sector." 
Who's Who Legal 2017 - France

 

Bureau

Paris

32 rue François 1er
75008
Paris

View office →

Qualifications

Professionnelles

Avocat au Barreau de Paris - 2000

Académiques

DESS Droit de Propriété Industrielle - Université Paris II, Panthéon Assas - 1999

DEA Droit Privé - Université Paris I, Panthéon Sorbonne - 1998

Expériences Pro Bono

  • Assistance de l'association "Autistes Sans Frontières"

Travaux publiés

  • ‘Brexit’: time is of the essence for life sciences innovators – LSIPR (Life Sciences Intellectual Property Review), Juin 2016
  • La juridiction unifiée du brevet (JUB) : un atout indéniable pour l'Europe, La Lettre des juristes d'affaires, Juillet 2014
  • La juridiction unifiée du brevet (JUB) reçoit un soutien croissant des entreprises, Option Droit et Finance, Juillet 2014 co-écrit avec David Por
  • Chapitre "France" du livre International Copyright Law, Global Law & Business – 2013, co-écrit avec Alexandre Rudoni et Olivia Klimis
  • L’Acte II de l’exception culturelle sur la scène du numérique, Les Echos, Juin 2013
  • "Overview of Life Sciences law in France" ,Chambers Life Sciences Guide 2013, co-écrit avec Olivier Fréget, David Por et Olivia Klimis
  • Interim injunctions over patents, The French practice, Managing Intellectual Property, co-écrit avec Olivia Klimis
  • Choisir la stratégie juridique adéquate pour valoriser sa marque - Décryptage avec Laëtitia Bénard, Les Echos, Décembre 2012
  • Comparative Advertising for generics in Germany and France after L’Oréal v Bellure, PTMG Law Lore & Practice, Décembre 2012, co-écrit avec Oscar Benito, Rainer Kaase et Ralf Möller
  • Il faut sauver le projet de Cour européenne des brevets, Option Droit & Affaires, Septembre 2012, co-écrit avec Olivia Klimis
  • Preliminary injunctions in Europe: an overview in the field of patents, The Handbook of European IP Management, Mai 2012
  • Trade secrets protection: a comparative overview, The Handbook of European IP Management, Mai 2012, co-écrit avec Benjamin Bai et Paul B. Keller
  • Why France is a good forum for preliminary injunctions in patent matters, Global Business Magazine, Avril 2012
  • Supplementary protection certificates: CJEU provides welcome clarifications, Who's Who Legal – Life Sciences, Avril 2012, co-écrit avec Olivia Klimis
  • Protéger les secrets d'affaires, Commerce International, Avril 2012
  • L'arrêt DHL/Chronopost de la CJUE du 12 avril 2011 : une injonction communautaire peut être obtenue dans les limites de l'atteinte aux fonctions de la marque, Lamy Droit de l'Immatériel, Août/septembre 2011, co-écrit avec Alexandra Abello
  • Concurrence, Santé Publique, Innovation et Médicament, LGDJ, 2010, sous la direction de Marie-Anne Frison-Roche
  • Médicaments Génériques et Droit de Propriété Industrielle, Lamy Droit de la Santé, 2002, 2004 et 2008
  • Question 202 du groupe français de l'AIPPI French sur "The impact of public health issues on exclusive patents rights", Septembre 2008
  • La Loi DADVSI en matière télévisuelle : Trois pas en arrière pour les titulaires de droits ? Légipresse, Mai 2007, co-écrit avec Alexandre Rudoni
  • Rights owners and users fail to agree on reform, Managing Intellectual Property, Juin 2006, co-écrit avec Alexandre Rudoni
  • Entrepreneurs d'une société de biotechnologie, comment vous préparer à une cession de votre entreprise, Bio Futur, Octobre 2005, co-écrit avec Alexandre Rudoni